Biomedical Science Clinical Trials This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory.
Novel Drug Shows Significant Promise in Treating Severe Stroke Patients
Remedy Pharmaceutical's drug may finally hold the answer to solving this medical dilemma NEW YORK--(BUSINESS WIRE)--Feb 6, 2012 - Each year, over 700,000 people in the United States suffer a stroke. For most, medical science can do very little.... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 6, 2012 Category: Pharmaceuticals Source Type: clinical trials
Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma
Condition: Hepatocellular CarcinomaIntervention: Biological: antiangiogenic paptide vaccineSponsors: Fukushima Medical University; Human Genome Center, Institute of Medical Science, University of TokyoRecruiting - verified December 2010 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 23, 2010 Category: Research Source Type: clinical trials
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer
Condition: Gastric CancerIntervention: Biological: peptide vaccineSponsors: Kinki University; Kinki University; Human Genome Center, Institute of Medical Science, University of TokyoCompleted - verified April 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2009 Category: Research Source Type: clinical trials
Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer
Condition: Bladder CancerIntervention: Biological: MPHOSPH1 and DEPDC1Sponsors: Iwate Medical University; Human Genome Center, Institute of Medical Science, University of TokyoActive, not recruiting - verified January 2009 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2008 Category: Research Source Type: clinical trials